Advances in vectored vaccines for poultry
Vaccine design technologies have made huge advances in recent years. One of the newer categories of vaccine, vectored vaccines, is overcoming challenges that conventional vaccines do not meet.
Search
100-year anniversary of BI in respiratory care
100-year anniversary of Boehringer Ingelheim in respiratory care
Geographic Atrophy
Geographic Atrophy is a slowly progressing, yet damaging form of AMD. Approximately 5 million people have Geographic Atrophy worldwide, with disease prevalence increasing with age. It is characterized by regions of cell death in the retina.
Spotlight on GPP
Emmanuelle Clerisme-Beaty, Head of Clinical Development and Medical Affairs, Dermatology, answers some frequently asked questions about GPP.
Jardiance®
Treatment of adults with type 2 diabetes mellitus as an adjunct to diet and exercise.
Living with type 2 diabetes
People living with type 2 diabetes often suffer a degree of stigma. Learn from Jurjen de Lange what it takes to live a good life despite the disease.
vaxxitek® hvt + ibd + nd
Bursal Disease-Marek's disease-Newcastle disease vaccine, serotype 3, live Marek's disease vector; the vaccine includes a diluent
IPF why wait?
IPF is a progressive and life threatening lung disease that can cause permanent damage in the lungs right from the start. Early diagnosis and treatment of IPF is critical, because acting quickly can make a difference.
COVID-19 Q&A for Patients
3 things you should know about avian influenza
Poultry farming communities across the globe are grappling once again with avian influenza
Bridging the gap in Generalized Pustular Psoriasis (GPP)
Emmanuelle Clerisme-Beaty, Head of Clinical Development and Medical Affairs, Dermatology, discusses recently published insights from GPP patients.
Patient Organizations
Boehringer Ingelheim’s core principles and vision guide our work with patient organisations.
10 things you should know about rabies
10 things you should know about rabies
Scleroderma Life Hacks
Video series featuring people living with scleroderma using everyday items in different ways to help them manage their symptoms. Part of the global 'More Than Scleroderma' initiative developed by Boehringer Ingelheim, with support from patient organi
Collaboration Driving Innovation
In conversation with Dr. Megan Grether, Global Head of Business Development & Licensing, Boehringer Ingelheim Animal Health.
Idiopathic Pulmonary Fibrosis treatment launched in Egypt
Idiopathic Pulmonary Fibrosis treatment launched in Egypt
Fighting against rabies in Nepal
Read about a pilot project of a critical importance which aims to raise awareness and knowledge of rabies in Nepal.
Newxxitek™ HVT+ND
The vaccination of 18 to 19-day-old embryos and one-day-old chickens is effective against Marek’s disease and Newcastle disease.
VAXXITEK HVT + IBD
To prevent mortality and to reduce clinical signs and lesions of infectious bursal disease. To reduce mortality, clinical signs and lesions of Marek’s disease.
Knowing the enemy: PRRS and PCVD
The swine industry is constantly vigilant of viruses such as PRRS and PCV2 (PCVD). Learn about prevention, symptoms knowledge, and control measures to make a difference.
Avinew
In broiler chickens from the age of one day of age: active immunisation against Newcastle disease to reduce mortality and clinical signs associated with the disease.
Parasites: What your pets can’t tell you!
Learn how our team in the East & Southeast Asia approached the topic of pet parasite issues in the region.
Fighting against rabies through vaccination and education
Dr. Silvina Muñiz is sharing her insights about rabies prevention and explains why education is essential.
Gallimune® / Gallivac® / Volvac®
For vaccination of healthy chickens against diseases caused by the included antigens.
Patient documentary - From diagnosis to everyday living
Patient documentary - From diagnosis to everyday living